Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy

Sponsor
Coloplast A/S (Industry)
Overall Status
Completed
CT.gov ID
NCT02675634
Collaborator
(none)
55
12
6
5
4.6
0.9

Study Details

Study Description

Brief Summary

This clinical investigation is intended to explore the performance and safety of two newly developed ostomy products with regard to the products fit to body properties.

Condition or Disease Intervention/Treatment Phase
  • Device: Coloplast Test A
  • Device: Coloplast Test B
  • Device: Subjects own product
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test A, Test B, Subjects own product

The subjects first test Coloplast Test A, followed by Coloplast Test B and finally Subjects own product

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Experimental: Test A, Subjects own product, Test B

The subjects first test Coloplast Test A, followed by Subjects own product, and finally Coloplast Test B

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Experimental: Test B, Test A, Subjects own product

The subjects first test Coloplast Test B, followed by Coloplast Test A and finally Subjects own product

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Experimental: Test B, Subjects own product, Test A

The subjects first test Coloplast Test B, followed by Subjects own product, and finally Coloplast Test A

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Experimental: Subjects own product, Test A, Test B

The subjects first test Subjects own product, followed by Test A, and finally Coloplast Test B

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Experimental: Subjects own product, Test B, Test A

The subjects first test Subjects own product, followed by Test B, and finally Coloplast Test A

Device: Coloplast Test A
Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Coloplast Test B
Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

Device: Subjects own product
The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.

Outcome Measures

Primary Outcome Measures

  1. Fit to Body [14 +/- 2 days]

    Subjects will evaluate the fit to body for each product by answering the question "how was the baseplates ability to fit the body contours in the area around the stoma?" The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Have given written informed consent and in DK: signed a letter of authority 2. Are at least 18 years of age and have full legal capacity 3. Have had their ileostomy or colostomy for at least 3 months 4. Are able to use a baseplate cut-max 15 to 40 mm 5. Are able to handle the product themselves 6. Currently using a 1-piece flat product 8. Willing to use an open bag size maxi during the investigation 9. Are able to use a custom cut (custom fit) product 10. Are suitable for participating in the investigation - this means that the subjects must be able to follow all elements of the study procedures.
Exclusion Criteria:
  1. Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis)

  2. Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid treatment (e.g. injection, or tablet) are allowed.

  3. Are pregnant or breastfeeding**

  4. Are participating in other interventional clinical investigations or have previously participated in this investigation

  5. Use irrigation during the investigation (flush the intestines with water, this is mostly for people with a colostomy)

  6. Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator)

  7. Have a loop ostomy (also called double barrel ostomy)

  8. Have known hypersensitivity towards any of the products used in the investigation

  • In DK: women in the child-bearing age will be ask to produce a negative pregnancy test and to sign a form ensuring the use of safe contraception during the investigation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Radiant Research Tempe Arizona United States 85282
2 Prism research center Saint Paul Minnesota United States 55114
3 Cleveland Clinic Cleveland Ohio United States 44195
4 TFS Søborg Denmark 2860
5 QPS Netherlands Groningen Netherlands 9713
6 Synexus Midlands Birmingham United Kingdom B15 2SQ
7 Pilgrim Hospital Boston United Kingdom
8 Illingworth Research Nurses Cheshire United Kingdom Sk11 6TG
9 Lincon Country hospital Lincoln United Kingdom LN25QY
10 Aintree University Hospital NHS Foundation Trust Liverpool United Kingdom l9 7AL
11 Kettering General hospital Northamptonshire United Kingdom NN168UZ
12 Synexus Hexam Northumberland United Kingdom NE46 1QJ

Sponsors and Collaborators

  • Coloplast A/S

Investigators

  • Study Chair: Camilla F Vibjerg, Head of Clinical Operation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Coloplast A/S
ClinicalTrials.gov Identifier:
NCT02675634
Other Study ID Numbers:
  • CP266
First Posted:
Feb 5, 2016
Last Update Posted:
Oct 16, 2017
Last Verified:
Sep 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No

Study Results

Participant Flow

Recruitment Details The subjects were recruited through the Coloplast A/S database and from hospital sites
Pre-assignment Detail
Arm/Group Title Test A, Test B, Subjects Own Product Test A, Subjects Own Product, Test B Test B, Test A, Subjects Own Product Test B, Subjects Own Product, Test A Subjects Own Product, Test A, Test B Subjects Own Product, Test B, Test A
Arm/Group Description The subjects first test Coloplast Test A, followed by Coloplast Test B and finally Subjects own product Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group. The subjects first test Coloplast Test A, followed by Subjects own product, and finally Coloplast Test B Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group. The subjects first test Coloplast Test B, followed by Coloplast Test A and finally Subjects own product Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group. The subjects first test Coloplast Test B, followed by Subjects own product, and finally Coloplast Test A Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group. The subjects first test Subjects own product, followed by Test A, and finally Coloplast Test B Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group. The subjects first test Subjects own product, followed by Test B, and finally Coloplast Test A Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.
Period Title: Test Period 1
STARTED 10 8 9 9 10 9
COMPLETED 10 7 8 8 10 9
NOT COMPLETED 0 1 1 1 0 0
Period Title: Test Period 1
STARTED 10 7 8 8 10 9
COMPLETED 9 7 8 8 10 8
NOT COMPLETED 1 0 0 0 0 1
Period Title: Test Period 1
STARTED 9 7 8 8 10 8
COMPLETED 9 7 8 8 10 8
NOT COMPLETED 0 0 0 0 0 0

Baseline Characteristics

Arm/Group Title The Study Population
Arm/Group Description This consists of all participants who were enrolled in the study
Overall Participants 55
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
69
(11.2)
Sex: Female, Male (Count of Participants)
Female
14
25.5%
Male
40
72.7%

Outcome Measures

1. Primary Outcome
Title Fit to Body
Description Subjects will evaluate the fit to body for each product by answering the question "how was the baseplates ability to fit the body contours in the area around the stoma?" The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.
Time Frame 14 +/- 2 days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Test A Test B Own Product
Arm/Group Description This is the result from all subjects evaluating Test A This is the results from all the subjects evaluating Test B this is the result from all the subjects evaluating Own product.
Measure Participants 51 54 51
Number [percentage of good or very good]
93
88
57

Adverse Events

Time Frame Adverse events were collected from subject enrollment to the subject left the study. Subjects with serious adverse events were followed until their condition was resolved.
Adverse Event Reporting Description
Arm/Group Title Test A Test B Own Product
Arm/Group Description This is the result from all subjects evaluating Test A This is the results from all the subjects evaluating Test B this is the result from all the subjects evaluating Own product.
All Cause Mortality
Test A Test B Own Product
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN) / (NaN)
Serious Adverse Events
Test A Test B Own Product
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 1/52 (1.9%) 0/54 (0%) 0/51 (0%)
Gastrointestinal disorders
Obstibation 1/52 (1.9%) 1 0/54 (0%) 0 0/51 (0%) 0
Other (Not Including Serious) Adverse Events
Test A Test B Own Product
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 8/52 (15.4%) 11/54 (20.4%) 4/51 (7.8%)
Skin and subcutaneous tissue disorders
Peristomal skin dermatitis 8/52 (15.4%) 8 11/54 (20.4%) 12 4/51 (7.8%) 5

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

Results Point of Contact

Name/Title Sara Gosk
Organization Scientific and Regulatory affairs
Phone +45 49113568
Email dksargo@coloplast.com
Responsible Party:
Coloplast A/S
ClinicalTrials.gov Identifier:
NCT02675634
Other Study ID Numbers:
  • CP266
First Posted:
Feb 5, 2016
Last Update Posted:
Oct 16, 2017
Last Verified:
Sep 1, 2017